President Donald Trump rolled back a Biden administration executive order aimed at lowering prescription drug prices, including an effort to make more generic drugs available to Medicare patients for ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
Teva Pharmaceuticals USA Inc. is taking the Biden administration to court over its drug price negotiation program, days ...
The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback